Palestine

Blog

  • Gender gap in teenage depression is twice as large in London than in Tokyo, new study finds

    Gender gap in teenage depression is twice as large in London than in Tokyo, new study finds

    Published in The Lancet Child & Adolescent Health, the study aimed to provide robust insights into adolescent mental health trajectories in two different cultural contexts by comparing large samples of 11 to 16 years olds in London and Tokyo over time. The two studies are the Tokyo Teen Cohort (TTC) and the Resilience Ethnicity and AdolesCent Mental Health (REACH) cohorts from South London. Both groups collected data in the period 2014 to 2020 and at three different time points as the…

    Continue Reading


    News Source: www.sciencedaily.com

  • Stroke rehabilitation drug repairs brain damage

    Stroke rehabilitation drug repairs brain damage

    A new study by UCLA Health has discovered what researchers say is the first drug to fully reproduce the effects of physical stroke rehabilitation in model mice, following from human studies.

    The findings, published in Nature Communications, tested two candidate drugs derived from their studies on the mechanism of the brain effects of rehabilitation, of which one resulted in significant recovery in movement control after stroke in the mouse model.

    Stroke is the leading cause of adult…

    Continue Reading


    News Source: www.sciencedaily.com

  • Letter from Mahmoud Khalil, a Palestinian political prisoner in Louisiana – Mondoweiss

    Letter from Mahmoud Khalil, a Palestinian political prisoner in Louisiana – Mondoweiss

    The following letter was dictated by Mahmoud Khalil to his lawyers over the phone from an ICE detention center

    March 18, 2025

    My name is Mahmoud Khalil and I am a political prisoner. I am writing to you from a detention facility in Louisiana where I wake to cold mornings and spend long days bearing witness to the quiet injustices underway against a great many people precluded from the protections of the law.

    Who has the right to have rights? It is certainly not the humans…

    Continue Reading


    News Source: mondoweiss.net

  • Two astronauts stuck in space for 9 months have returned to Earth

    Two astronauts stuck in space for 9 months have returned to Earth

    Astronauts Suni Williams and Butch Wilmore’s extended stay in the International Space Station will add to what we know about how space affects health.

    Continue Reading


    News Source: www.sciencenews.org

  • Palestinians across Gaza awake to new Israeli massacre

    Palestinians across Gaza awake to new Israeli massacre

    I heard the missile before it exploded. It was 2 a.m., and I had just woken up to pray and read the Quran. I went to the bathroom, when suddenly the door swung open: our home shook with the bomb’s impact. We later learned that one of our neighbors’ houses, in the Al-Fukhari neighborhood in Khan Younis, had been directly targeted.

    Across the Gaza Strip, Palestinians awoke to the resumption of Israel’s genocidal war. The army claimed to be targeting “terrorist…

    Continue Reading


    News Source: www.972mag.com

  • Non-genetic theories of cancer address inconsistencies in current paradigm

    Non-genetic theories of cancer address inconsistencies in current paradigm

    It’s time for researchers to reconsider the current paradigm of cancer as a genetic disease, argued Sui Huang from the Institute for Systems Biology, USA, and colleagues in a new essay published March 18 in the open-access journal PLOS Biology.

    The prevailing theory on the origin of cancer is that an otherwise normal cell accumulates genetic mutations that allow it to grow and reproduce unchecked. This paradigm has driven large-scale cancer genome sequencing projects, such as The Cancer…

    Continue Reading


    News Source: www.sciencedaily.com

  • Researchers find missing link in autoimmune disorder

    Researchers find missing link in autoimmune disorder

    Autoimmune diseases, which are estimated to affect more than 15 million people in the U.S., occur when the body responds to immune-system false alarms, and infection-fighting first responders are sent out to attack threats that aren’t there. Scientists have long understood how the false alarms get triggered, but the second step of dispatching the immune response has been a mystery.

    Now, scientists at Washington University School of Medicine in St. Louis and the Perelman School of Medicine at…

    Continue Reading


    News Source: www.sciencedaily.com

  • Whose air quality are we monitoring?

    Whose air quality are we monitoring?

    U.S. Environmental Protection Agency (EPA) air quality monitors are disproportionally located in predominately white neighborhoods, according to University of Utah research. The EPA’s network consistently failed to capture air quality in communities of color across six major pollutants, particularly lead and sulfur dioxide, followed by ozone and carbon monoxide.

    EPA regulatory monitors are the key data source driving decisions about pollution reduction, urban planning and public health…

    Continue Reading


    News Source: www.sciencedaily.com

  • Vaccine may improve breast cancer treatment outcomes

    Vaccine may improve breast cancer treatment outcomes

    Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen receptor-negative (HER2-positive, ER-negative) breast cancer and has shown encouraging results in a recent pilot study. Published in npj Breast Cancer, the study combined the HER2-targeting dendritic cell vaccines with standard chemotherapy, demonstrating both safety and…

    Continue Reading


    News Source: www.sciencedaily.com

  • Latest Alzheimer’s drug shown less effective in females than males

    Latest Alzheimer’s drug shown less effective in females than males

    Since becoming only the second Alzheimer’s-modifying drug to gain American Federal Drug Administration approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.

    In its Phase 3 clinical trial, lecanemab slowed cognitive decline by 27 per cent overall, yet one subset of data suggested little to no benefit in females, though the cause of the difference was not clear. An FDA committee voted unanimously that…

    Continue Reading


    News Source: www.sciencedaily.com